 Choosing sample size for a clinical trial using decision analysisYi Cheng Biometrika, 2003, vol. 90, issue 4, 923-936 Abstract: Consider designing a clinical trial in stages, with two treatments and N exchangeable patients to be treated. Responses are dichotomous. The problem is to decide how large each stage should be and how many patients should be assigned to each treatment during each stage. Information is updated during and after each stage using Bayes' theorem. In planning stage j, responses from selections in stages 1 to j - 1 are available, but interim responses in stage j are not available. Our analytical results consider two stages for two scenarios, when one treatment arm is known and when both treatment arms are unknown. The dominant term for the length of the first stage in an optimal design for general N is found explicitly. In both scenarios the order of magnitude of the length of the first stage is the square root of N. The finite-N performance of asymptotically optimal allocation is compared with that of the true optimal allocation. Our numerical study also shows that, for a trial of three stages with one known arm, the optimal first-stage sample size is asymptotically proportional to the cube root of N. Copyright Biometrika Trust 2003, Oxford University Press. Date: 2003 There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:oup:biomet:v:90:y:2003:i:4:p:923-936 Ordering information: This journal article can be ordered from Access Statistics for this article Biometrika is currently edited by Paul Fearnhead More articles in Biometrika from Biometrika Trust Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK. |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.